MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

R6/2 Transgenic Mouse Model

R6/2 Transgenic Mouse Model

R6/2 mice model human Huntington’s disease (HD) by expressing a portion of the human HD gene under human gene promoter elements (1 kb of 5 UTR sequence and exon 1 together with ~120 CAG repeats). Expression of this amino-terminal fragment of the huntingtin protein with its polyglutamine expansion is sufficient to generate the phenotype of human HD.

The most important characteristics of R6/2 mice are:
  • HTT aggregates
  • Reduced activity
  • Motor deficits
  • Learning and relearning deficits
  • Reduced anxiety
  • Neuroinflammation
  • Striatal alterations
  • Neuronal atrophy
  • Mean survival of 100 days

Progressive motor deficits of R6/2 mice start at the age of 6 weeks and can be measured with the RotaRod test. The two choice swim test allows evaluation of cognitive deficits in R6/2 at the age of 10 weeks (Figure 1).

R62I

Figure 1 (A): RotaRod performance of R6/2 mice: Motor coordination expressed as time until falling off the rod with progressing age (tg: n = 10; ntg: n = 19); (B) two choice swim test: percentage of wrong choices during 5 training days with 5 trials per day followed by one reversal day with 15 trials (n = 14 per group); two-way ANOVA with Bonferroni`s post hoc test. Mean ± SEM. **p<0.01; ***p<0.001.

Astrocytosis as measure of neuroinflammation in R6/2 mice can be observed in the cortex and hippocampus at the age of 15 weeks (Figure 2).

R62

Figure 2: Astrocytosis in R6/2 mice: R6/2 mice feature increased levels of astrocytosis compared to ntg controls. GFAP (astrocytes, red) plus DAPI (nuclei, blue) in the primary somatosensory cortex and CA1 region of the hippocampus.

QPS Neuropharmacology offers a custom-tailored study design for R6/2 mice, and we are flexible to accommodate your special interests. We are also happy to advise you and propose study designs. R6/2 mice show a relevant HD phenotype at the age of 6 weeks. This grants a remarkable fast processing time of your HD study. Furthermore, non-transgenic littermates are available as control animals needed for proper study design.

We are happy to evaluate the efficacy of your compound in the R6/2 mouse model! The most common readouts are:

Looking for something else? Please contact us!

You might be also interested in these related topics:

We are happy to receive your inquiry.

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE